0.78
price down icon2.80%   -0.0225
pre-market  Pre-mercato:  .81   0.03   +3.85%
loading

Iterum Therapeutics Plc Borsa (ITRM) Ultime notizie

pulisher
07:23 AM

Using Ichimoku Cloud for Iterum Therapeutics plc technicalsAI Entry Timing Prediction for Swing Traders - Newser

07:23 AM
pulisher
06:28 AM

Is Iterum Therapeutics plc showing signs of accumulationPortfolio Allocation Strategy for Stability - Newser

06:28 AM
pulisher
05:02 AM

Best data tools to analyze Iterum Therapeutics plc stockFree Proven Entry Plan With Low Risk Trade - Newser

05:02 AM
pulisher
Jul 28, 2025

How strong is Iterum Therapeutics plc company’s balance sheetMarket Forecast Target Finder For 2025 - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Iterum Therapeutics plc stockMaximize gains with data-driven stock picks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Iterum Therapeutics plc in the next 12 monthsUnmatched market performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How to use a screener to detect Iterum Therapeutics plc breakoutsDaily Market Momentum and Pressure Analysis - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What moving averages say about Iterum Therapeutics plcStock Entry Point Planner with Volume Spike - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Iterum Therapeutics plc stockUnlock daily stock market insights for success - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Iterum Therapeutics plc Company Revenue and Profit Trends: A Deep DiveTrend Following Trades - metal.it

Jul 27, 2025
pulisher
Jul 25, 2025

Iterum Therapeutics plc Stock Analysis and ForecastFree Stock Market Trend Analysis - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Is Iterum Therapeutics plc a good long term investmentSuperior risk-adjusted returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Iterum Therapeutics plc stock priceConsistently exceptional gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Iterum Therapeutics Plc (ITRM) Stock: A Year of Market Movement, Down and Up - investchronicle.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Iterum Therapeutics plc stockHigh-profit capital plays - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 15, 2025

Why Iterum Therapeutics plc stock attracts strong analyst attentionMassive Profit Potential - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Iterum Therapeutics plc stock price move sharplyWatchlist Winner Update - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Iterum Therapeutics plc stock performs during market volatilityFree Access to Investment Community - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

OneDigital Investment Advisors LLC Invests $124,000 in Iterum Therapeutics PLC (NASDAQ:ITRM) - Defense World

Jul 14, 2025
pulisher
Jul 08, 2025

Iterum Therapeutics (NASDAQ:ITRM) Trading Down 4.2% – Here’s What Happened - Defense World

Jul 08, 2025
pulisher
Jul 05, 2025

Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Jul 05, 2025
pulisher
Jun 30, 2025

Iterum Strengthens Launch Strategy: 30-Year Pharma Veteran Christine Coyne to Lead ORLYNVAH Commercialization - Stock Titan

Jun 30, 2025
pulisher
Jun 30, 2025

Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH™ Launch and Commercial Growth - Yahoo Finance

Jun 30, 2025
pulisher
Jun 29, 2025

Certain Options of Iterum Therapeutics plc are subject to a Lock-Up Agreement Ending on 30-JUN-2025. - MarketScreener

Jun 29, 2025
pulisher
Jun 29, 2025

Certain Ordinary Shares of Iterum Therapeutics plc are subject to a Lock-Up Agreement Ending on 30-JUN-2025. - MarketScreener

Jun 29, 2025
pulisher
Jun 25, 2025

Iterum Therapeutics (ITRM) Releases Positive Phase 3 Trial Resul - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Iterum Therapeutics (ITRM) Releases Positive Phase 3 Trial Results | ITRM Stock News - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

New Antibiotic Shows Promise Against Drug-Resistant UTIs: NEJM Evidence Reveals 9.2% Multi-Resistance Rate - Stock Titan

Jun 25, 2025
pulisher
Jun 17, 2025

Transcript : Iterum Therapeutics plcSpecial Call - MarketScreener

Jun 17, 2025
pulisher
Jun 14, 2025

Research Analysts Set Expectations for ITRM FY2026 Earnings - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Invests $45,000 in Iterum Therapeutics plc (NASDAQ:ITRM) - Defense World

Jun 14, 2025
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Capitalizzazione:     |  Volume (24 ore):